Evaluating the Role of Cystatin C and Creatinine as Markers of Renal Recovery in Critically Ill Patients After Acute Kidney Injury.
1 other identifier
observational
336
1 country
1
Brief Summary
This is a cohort study in which patients who survive Acute Kidney Injury (AKI) during intensive care unit (ICU) admission are recalled at 3-6 months and renal function tests are performed. The purpose of the study is describe renal function in AKI survivors at follow-up. Additional aims are to determine how well admission values of renal function markers perform as predictors of renal function at follow-up and whether estimates of renal function at follow-up differ depending on which renal function marker is used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 9, 2016
CompletedAugust 23, 2017
August 1, 2017
3.9 years
September 5, 2016
August 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Renal function
Renal function as defined by estimated glomerular filtration rate (eGFR)using seri Creatinine and Cystatin C at follow-up
3-9 months
Secondary Outcomes (1)
Mortality
2 years
Interventions
Eligibility Criteria
Patients admitted to the central intensive care unit at Karolinska University hospital, who suffered from AKI during the period September 2008 until May 2011.
You may qualify if:
- Adults treated on Intensive care with AKI (RIFLE criteria)
- Survival 3 months after discharge.
- Admission during September 2008-May 2011
You may not qualify if:
- Under 18 years
- Unable to give consent.
- Admission during a time when study staff not working.
- Death before 3 month follow-up
- No Swedish personal identification number
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karolinska Institute
Stockholm, 171 77, Sweden
Related Publications (1)
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Aug;8(4):R204-12. doi: 10.1186/cc2872. Epub 2004 May 24.
PMID: 15312219BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Max Bell, PhD
Karolinska Institutet
- PRINCIPAL INVESTIGATOR
Johan Mårtensson, PhD
Karolinska Institutet
- PRINCIPAL INVESTIGATOR
Claes-Roland Martling, PhD
Karolinska Institutet
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
September 5, 2016
First Posted
September 9, 2016
Study Start
January 1, 2008
Primary Completion
December 1, 2011
Study Completion
December 1, 2014
Last Updated
August 23, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share
Data is anonymised and data regarding individuals will not be published.